• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唑来膦酸和阿仑膦酸处理的破骨细胞中 pH 值的影响。

Influence of pH on osteoclasts treated with zoledronate and alendronate.

机构信息

Biomedical Group (BIO277), Department of Stomatology, School of Dentistry, University of Granada, Granada, Spain.

Instituto Investigación Biosanitaria, ibs.Granada, Granada, Spain.

出版信息

Clin Oral Investig. 2019 Feb;23(2):813-820. doi: 10.1007/s00784-018-2505-z. Epub 2018 Jun 6.

DOI:10.1007/s00784-018-2505-z
PMID:29876664
Abstract

OBJECTIVES

The objectives of this study were to analyze the effect of pH on the growth and activity of osteoclasts treated with different doses of two nitrogen-containing BPs, zoledronate and alendronate.

MATERIALS AND METHODS

Murine osteoclasts cultured on dentine disks were treated with zoledronate (50 or 500 nM) or alendronate (500 or 5 μM) at two different pH values (7.4 or 7.0). Osteoclasts were counted with transmitted light microscopy, apoptosis/necrosis was studied with flow cytometry and confocal microscopy, and resorption pit number and depth were calculated using reflected light and scanning electron microscopy.

RESULTS

The osteoclast count on dentine disks was significantly (p < 0.001) reduced by zoledronate or alendronate treatment at pH 7.0 in comparison to treatment with the same doses at pH 7.4 and untreated disks (controls). The percentage of apoptotic cells was significantly increased by treatment with 500 nM zoledronate or 5 μM alendronate at pH 7.0 in comparison to the same doses at pH 7.4. The number and depth of resorption pits were significantly lower in disks treated at each BP dose studied than in untreated controls at pH 7.0.

CONCLUSIONS

Zoledronate and alendronate at therapeutic doses have an adverse effect on the viability and resorptive activity of osteoclasts when the local medium pH is reduced.

CLINICAL RELEVANCE

These findings suggest that periodontal or peri-implant oral cavity infection may be a key trigger of the cascade of events that lead to BRONJ.

摘要

目的

本研究旨在分析不同剂量两种含氮双膦酸盐(唑来膦酸和阿仑膦酸钠)作用于破骨细胞时 pH 值对其生长和活性的影响。

材料和方法

在 dentine 盘上培养的鼠破骨细胞分别用不同剂量(50 或 500nM)的唑来膦酸或(500 或 5μM)阿仑膦酸钠在两种不同 pH 值(7.4 或 7.0)下进行处理。用透射光显微镜对破骨细胞进行计数,用流式细胞术和共聚焦显微镜研究细胞凋亡/坏死,用反射光和扫描电子显微镜计算蚀斑数量和深度。

结果

与 pH 7.4 相同剂量处理组和未处理(对照组)相比,在 pH 7.0 时,唑来膦酸或阿仑膦酸钠处理明显(p<0.001)减少了 dentine 盘上的破骨细胞计数。与 pH 7.4 相同剂量处理组相比,在 pH 7.0 时,用 500nM 唑来膦酸或 5μM 阿仑膦酸钠处理时,凋亡细胞的百分比明显增加。与 pH 7.0 时未处理的对照组相比,在每个研究的 BP 剂量处理的盘上,蚀斑的数量和深度均显著降低。

结论

在局部介质 pH 值降低时,唑来膦酸和阿仑膦酸钠在治疗剂量下对破骨细胞的活力和吸收活性有不良影响。

临床相关性

这些发现表明,牙周或种植体周围口腔感染可能是导致 BRONJ 的一系列事件的关键触发因素。

相似文献

1
Influence of pH on osteoclasts treated with zoledronate and alendronate.唑来膦酸和阿仑膦酸处理的破骨细胞中 pH 值的影响。
Clin Oral Investig. 2019 Feb;23(2):813-820. doi: 10.1007/s00784-018-2505-z. Epub 2018 Jun 6.
2
The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.含氮双膦酸盐(唑来膦酸和阿仑膦酸钠)对成骨细胞促血管生成因子产生的影响。
Cytokine. 2015 Feb;71(2):154-60. doi: 10.1016/j.cyto.2014.10.025. Epub 2014 Nov 17.
3
Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.可视化破骨细胞和非吸收细胞对双膦酸盐的矿物质结合及摄取情况。
Bone. 2008 May;42(5):848-60. doi: 10.1016/j.bone.2007.12.225. Epub 2008 Jan 26.
4
Bisphosphonates inhibit surface-mediated osteogenesis.双膦酸盐抑制表面介导的成骨作用。
J Biomed Mater Res A. 2020 Aug 1;108(8):1774-1786. doi: 10.1002/jbm.a.36944. Epub 2020 Apr 21.
5
Giant osteoclast formation and long-term oral bisphosphonate therapy.巨大破骨细胞形成与长期口服双膦酸盐治疗。
N Engl J Med. 2009 Jan 1;360(1):53-62. doi: 10.1056/NEJMoa0802633.
6
Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.去除基质结合唑来膦酸可通过挽救破骨细胞功能来预防拔牙后颌骨坏死。
Bone. 2018 May;110:141-149. doi: 10.1016/j.bone.2018.01.030. Epub 2018 Feb 9.
7
Nitrogen Containing Bisphosphonates Impair the Release of Bone Homeostasis Mediators and Matrix Production by Human Primary Pre-Osteoblasts.含氮双膦酸盐可抑制人原代前成骨细胞释放骨稳态介质和基质产生。
Int J Med Sci. 2019 Jan 1;16(1):23-32. doi: 10.7150/ijms.27470. eCollection 2019.
8
Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.佐剂性关节炎大鼠胫骨近端和远端骨质疏松症中破骨细胞形成的差异:双膦酸盐对破骨细胞的抑制作用
Mod Rheumatol. 2006;16(6):343-9. doi: 10.1007/s10165-006-0515-1. Epub 2006 Dec 20.
9
Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.口服双膦酸盐和三种静脉用双膦酸盐对几种细胞类型的体外影响。
Clin Oral Investig. 2018 Sep;22(7):2527-2534. doi: 10.1007/s00784-018-2349-6. Epub 2018 Feb 1.
10
Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.依替膦酸(一种非含氮双膦酸盐)对含氮双膦酸盐(NBPs)坏死作用的抑制及其从骨中的清除:关于依替膦酸可能用作NBPs替代药物的提议。
J Oral Maxillofac Surg. 2010 May;68(5):1043-54. doi: 10.1016/j.joms.2009.08.027. Epub 2010 Feb 13.

引用本文的文献

1
Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review.接受唑来膦酸或阿仑膦酸治疗的患者发生颌骨坏死的风险:一项系统评价
Medicina (Kaunas). 2025 Jun 26;61(7):1159. doi: 10.3390/medicina61071159.
2
Increased apoptosis of gingival epithelium is associated with impaired autophagic flux in medication-related osteonecrosis of the jaw.药物相关性颌骨骨坏死中牙龈上皮细胞凋亡增加与自噬流受损有关。
Autophagy. 2023 Nov;19(11):2899-2911. doi: 10.1080/15548627.2023.2234228. Epub 2023 Jul 21.
3
Aloe polysaccharide promotes osteogenesis potential of adipose-derived stromal cells via BMP-2/Smads and prevents ovariectomized-induced osteoporosis.

本文引用的文献

1
Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.双膦酸盐对不同成骨细胞生理标志物基因表达的调节:在双膦酸盐相关性颌骨骨坏死中的潜在意义。
Int J Med Sci. 2018 Feb 12;15(4):359-367. doi: 10.7150/ijms.22627. eCollection 2018.
2
Effect of 1% sodium alendronate in the non-surgical treatment of periodontal intraosseous defects: a 6-month clinical trial.1%阿仑膦酸钠在牙周骨内缺损非手术治疗中的作用:一项为期6个月的临床试验
J Appl Oral Sci. 2017 May-Jun;25(3):310-317. doi: 10.1590/1678-7757-2016-0252.
3
芦荟多糖通过 BMP-2/Smads 促进脂肪来源的基质细胞的成骨潜能,并预防去卵巢诱导的骨质疏松症。
Mol Biol Rep. 2022 Dec;49(12):11913-11924. doi: 10.1007/s11033-022-08003-x. Epub 2022 Oct 15.
4
The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors.阿仑膦酸钠对不同浓度巨噬细胞集落刺激因子和核因子κB 受体活化因子配体生长因子组合诱导的破骨细胞生成的影响。
Biomolecules. 2021 Mar 16;11(3):438. doi: 10.3390/biom11030438.
5
Impact of bisphosphonates on the proliferation and gene expression of human fibroblasts.双膦酸盐对人成纤维细胞增殖和基因表达的影响。
Int J Med Sci. 2019 Oct 21;16(12):1534-1540. doi: 10.7150/ijms.36994. eCollection 2019.
6
Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures.唑来膦酸减少老年股骨粗隆间骨折术后患者急性骨丢失及骨折发生率的研究。
Orthop Surg. 2019 Jun;11(3):380-385. doi: 10.1111/os.12460. Epub 2019 May 6.
Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers.
1%阿仑膦酸盐凝胶作为辅助机械治疗手段在吸烟者慢性牙周炎治疗中的作用
J Appl Oral Sci. 2017 May-Jun;25(3):243-249. doi: 10.1590/1678-7757-2016-0201.
4
High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.高剂量双膦酸盐通过使细胞周期停滞并诱导细胞凋亡来降低成骨样细胞的增殖。
J Craniomaxillofac Surg. 2015 Apr;43(3):396-401. doi: 10.1016/j.jcms.2014.12.008. Epub 2014 Dec 19.
5
Effects on growth of human osteoblast-like cells of three nonsteroidal anti-inflammatory drugs: metamizole, dexketoprofen, and ketorolac.三种非甾体抗炎药:安乃近、右酮洛芬和酮咯酸对人成骨样细胞生长的影响。
Biol Res Nurs. 2015 Jan;17(1):62-7. doi: 10.1177/1099800414527155. Epub 2014 Mar 12.
6
Nitrogen-containing bisphosphonates modulate the antigenic profile and inhibit the maturation and biomineralization potential of osteoblast-like cells.含氮双膦酸盐可调节抗原谱并抑制成骨样细胞的成熟和生物矿化潜能。
Clin Oral Investig. 2015 May;19(4):895-902. doi: 10.1007/s00784-014-1309-z. Epub 2014 Aug 28.
7
A decade of bisphosphonate bone complications: what it has taught us about bone physiology.十年双磷酸盐类药物相关骨并发症:对骨生理学的启示
Int J Oral Maxillofac Implants. 2014 Mar-Apr;29(2):e247-58. doi: 10.11607/jomi.te61.
8
Rodent osteoclast cultures.啮齿动物破骨细胞培养物。
Methods Mol Biol. 2012;816:103-17. doi: 10.1007/978-1-61779-415-5_8.
9
Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts.双膦酸盐调节人骨髓间充质干细胞来源的成骨细胞中 OPG 和 M-CSF 的表达。
Clin Oral Investig. 2012 Aug;16(4):1153-9. doi: 10.1007/s00784-011-0614-z. Epub 2011 Sep 22.
10
Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.颌骨骨坏死与双膦酸盐相关 - 特征、危险因素、临床特征、定位及对肿瘤治疗的影响。
J Craniomaxillofac Surg. 2012 Jun;40(4):303-9. doi: 10.1016/j.jcms.2011.05.003. Epub 2011 Jun 14.